Sanofi

Toujeo insulin gets Scottish go ahead

9th September 2015

Sanofi’s Toujeo® (Insulin glargine 300 units/mL) has been approved for use in Scotland, the pharmaceutical company has announced. The Scottish Medicines Consortium (SMC) has approved the ...

Read more

Inhaled insulin available in US

13th February 2015

An inhaled insulin has gone on sale in America this month. Afrezza, developed by MannKind and licensed to pharmaceutical company Sanofi, is available in the US market for people with Type 1 or ...

Read more

Sanofi release children’s diabetes app

7th September 2014

A new app to encourage children to learn more about how to live with diabetes has been launched. Mission T1D by Sanofi Diabetes is aimed at children with Type 1 diabetes and their parents and ...

Read more